How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Avsola cost savings if eligible
If you are eligible for the Avsola patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Avsola through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Avsola patient assistance program?
You could receive your Avsola without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Avsola patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Avsola.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Avsola patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Avsola medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx an Avsola coupons provider?
At NiceRx, we help eligible individuals access the Avsola patient assistance program. This means that we are not an Avsola coupon, an Avsola discount card, or an Avsola copay card provider. We do not offer any medication trial offers, or free Avsola samples.
Can NiceRx help me get Avsola if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Avsola medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Avsola cost without insurance?
Avsola costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Avsola intravenous powder for injection axxq 100 mg will typically cost around $530 for 1 powder for injection. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Avsola cost with insurance?
The copay of Avsola will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Avsola?
Avsola is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Amgen. It is biosimilar to Remicade (infliximab), which means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product and that there are no clinically meaningful differences between the biosimilar product and the reference product.
Avsola is a tumor necrosis factor (TNF) blocker indicated for:
- Active Crohn’s Disease – to reduce the signs and symptoms and induce and maintain clinical remission in adult patients with moderately to severely active disease who have not responded to conventional therapy, and to reduce the number of draining enterocutaneous and rectovaginal fistulas and maintain fistula closure in adult patients with fistulizing disease
- Pediatric Crohn’s Disease – to reduce the signs and symptoms and induce and maintain clinical remission in pediatric patients with moderately to severely active disease who have had an inadequate response to conventional therapy
- Ulcerative colitis – to reduce the signs and symptoms, induce and maintain clinical remission and mucosal healing, and eliminate corticosteroid use in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
- Pediatric ulcerative colitis – reducing the signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active disease who have had an inadequate response to conventional therapy
- Rheumatoid arthritis in combination with methotrexate – reducing the signs and symptoms, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active disease
- Ankylosing spondylitis – reducing the signs and symptoms in patients with active disease
- Psoriatic arthritis – reducing the signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function
- Plaque psoriasis – treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate
See the full prescribing information for the complete boxed warning:
- Increased risk of serious infections leading to hospitalization or death, including tuberculosis, bacterial sepsis, invasive fungal infections, and infections due to other opportunistic pathogens
- Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with tumor necrosis factor (TNF) blockers, including infliximab products
- Postmarketing cases of fatal hepatosplenic T-cell lymphoma (HSTCL) have been reported in patients treated with TNF-blockers, including infliximab products. Almost all had received azathioprine or 6-mercaptopurine with a TNF-blocker at or before diagnosis. Most cases were reported in patients with Crohn’s disease or ulcerative colitis, most of whom were adolescent or young adult males
What doses of Avsola are available?
Avsola is available in injection form, in the following doses: 100 mg of lyophilized infliximab-axxq in a 20 mL single-dose vial for intravenous infusion.
Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Avsola active ingredients
Avsola contains infliximab-axxq as the active ingredient.
Avsola side effects
The most common side effects of Avsola in clinical trials include:
- Risk of infections
- Infusion-related reactions
- Abdominal pain
In rare instances, Avsola can cause more serious side effects. These can include:
- Serious infections
- Invasive fungal infections
- Hepatitis B virus reactivation
- Heart failure – new onset or worsening symptoms
- Hypersensitivity – serious infusion reactions including anaphylaxis or serum sickness-like reactions may occur
- Cardiovascular and cerebrovascular reactions – cerebrovascular accidents, myocardial infarctions (some fatal), and arrhythmias have been reported during and within 24 hours of initiation of infliximab product infusion
- Demyelinating disease – exacerbation or new-onset may occur
- Lupus-like syndrome
Your doctor will assess the benefits of using Avsola against your risk of side effects. Patients are encouraged to report adverse effects or adverse reactions of Avsola to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Avsola drug interactions
Avsola can interact with other medications. These include:
- Anakinra or abatacept – increased risk of serious infections
- Live vaccines or therapeutic infectious agents
This list is not exhaustive and other prescription drugs may interact with Avsola. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You should not use Avsola if you:
- Are allergic to the active ingredient infliximab-axxq
- Have had an allergic reaction to any of the other ingredients in Avsola
- Are breastfeeding or are planning to breastfeed
Talk to your doctor before using Avsola if you:
- Are taking any of the medications that could interact with Avsola
- Are younger than 6 years of age
- Have an active infection
- Have moderate to severe heart failure or other heart problems
- Have diabetes
- Have a weak immune system
- Have liver failure, hepatitis B, or any other liver problems
- Have chronic obstructive pulmonary disease (COPD)
- Have cancer
- Suffer from seizures
- Have multiple sclerosis or Guillain-Barré syndrome
- Have phototherapy for psoriasis
- Are scheduled to receive any vaccines
- Are pregnant or are planning to become pregnant
Avsola is the trademark brand name for infliximab-axxq manufactured by Amgen. A generic version of infliximab-axxq is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Avsola savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.